Neural Functioning of Feeding Centers in Obese Youth

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT01808846
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
51
1
79.1
0.6

Study Details

Study Description

Brief Summary

To explore whether obese adolescents with insulin resistance and relative low leptin levels exhibit functional alterations of the neuronal circuits involved in the regulation of energy metabolism and food seeking behaviors.

We here propose to test the hypothesis that the reward circuitry is dysregulated in obese adolescents and is related to the degree of insulin resistance and hyperinsulinemia.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Functional Magnetic Resonance Imaging (fMRI) provides a non-invasive method to assess the functional pathways affected by nutrient ingestion and therefore can help answer important questions regarding potential differences in the response of brain regions involved in feeding.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    51 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Neural Functioning of Feeding Centers in Obese Youth
    Actual Study Start Date :
    Jul 1, 2010
    Actual Primary Completion Date :
    Feb 1, 2017
    Actual Study Completion Date :
    Feb 1, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    Lean Adolescents

    Kids aged 12-17 with body mass index less than 25% and normal glucose tolerance test results

    Obese Insulin Sensitive

    Obese Insulin Sensitive Adolescents aged 12-17 with BMI>95th% and whole body insulin sensitivity index > 3.

    Obese Insulin Resistant Adolscent

    Obese Insulin Resistant Adolescents 12-17 with BMI> 95th% and WBISI<1.2.

    Outcome Measures

    Primary Outcome Measures

    1. measure of cerebral blood flow response to glucose ingestion [Baseline and 2 year follow up]

      fmri on 3T to measure blood flow response after ingestion of glucose drink

    Secondary Outcome Measures

    1. measure of cerebral blood flow response to fructose ingestion [Baseline and 2 year follow up]

      fmri on 3T to measure blood flow response after ingestion of fructose drink

    Other Outcome Measures

    1. measure of BOLD signal brain reactivity to food cues [Baseline and 2 year follow up]

      fmri on 3T to measure blood flow response to visually presented food cues

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 17 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Obese adolescents

    • Good general health,

    • taking no medication on a chronic basis

    • Age 12 to 17 yrs,

    • in puberty (girls and boys: Tanner stage II - IV)

    Obese Insulin Resistant Adolescents

    • (BMI> 95th)

    • (WBISI<1.2 plus a low adiponectin <6 ug/dl and

    • high triglyceride levels >130mg/dl)

    Obese Insulin Sensitive Adolescents

    • (BMI>95th)

    • (WBISI >3) plus high adiponectin >8 ug/ml and

    • triglyceride levels > 80 mg/dl Girls who begin menstruating must have a negative pregnancy test during the study

    Eligibility criteria for healthy non-obese children and adolescents:
    • Brother or sister with obesity

    • Age 12 to 17 years

    • Normal fasting glucose and lipids in the child, and

    • normal OGTT

    • No use of any medication known to affect glucose, lipid metabolism and inflammation

    • No endocrinopathies

    • No use of any antipsychotic medication

    • BMI >25th to <75th ( Center for Disease Control (CDC) BMI Charts)

    • Minimum weight of 90lbs (CDC Growth Charts)

    Exclusion Criteria

    • Baseline creatinine >1.0 mg

    • Pregnancy

    • Presence of endocrinopathies (e.g. Cushing syndrome)

    • Cardiac or pulmonary or other significant chronic illness

    • Adolescents with psychiatric disorder or with substance abuse determined via self-report.

    • Use of anorexic agents No metal implants

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Yale University New Haven Connecticut United States 06510

    Sponsors and Collaborators

    • Yale University
    • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    Investigators

    • Principal Investigator: Sonia Caprio, M.D., Yale University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sonia Caprio, Professor of Pediatrics, Yale University
    ClinicalTrials.gov Identifier:
    NCT01808846
    Other Study ID Numbers:
    • 1001006251
    • R01DK085577
    First Posted:
    Mar 11, 2013
    Last Update Posted:
    Apr 27, 2017
    Last Verified:
    Apr 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Sonia Caprio, Professor of Pediatrics, Yale University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 27, 2017